Literature DB >> 6319150

Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers.

L A Stevens, C D Bevan, J Salmon, J Krieger, M Perianu, A LeGo.   

Abstract

The pharmacokinetics of loprazolam have been studied in eight healthy male volunteers after single and repeated 2 mg oral doses taken at night, for eight nights. The absorption and disposition of unchanged drug (HPLC-GC assay) and receptor active benzodiazepine-type materials (radioreceptor assay) were examined after the first and eighth dose. Maximum levels of approximately 10 ng ml-1 (range 3.6 to 15.5 ng ml-1) were reached within about 2.5 h after dosing. The post-peak levels declined in a single exponential fashion with an overall mean +/- SD half-life of 7.06 +/- 1.98 h and total areas under the curve ranging from 35.9 to 189.0 ng ml-1 h. There were no statistical differences between the values for the first and eighth doses. There was no evidence to suggest that significant accumulation of parent drug or receptor active benzodiazepine-type materials had occurred, and it is concluded that the kinetics of loprazolam would allow repeated daily doses of 2 mg.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6319150     DOI: 10.1007/bf00542354

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  The use of confidence intervals in biopharmaceutics.

Authors:  E Shirley
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

2.  Effects of benzodiazepines on sleep and wakefulness.

Authors:  T Roth; F Zorick; J Sicklesteel; E Stepanski
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

3.  The use of short- and long-acting hypnotics in clinical medicine.

Authors:  A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

4.  Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics.

Authors:  D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

5.  A radioreceptor assay for benzodiazepines.

Authors:  P Hunt; J M Husson; J P Raynaud
Journal:  J Pharm Pharmacol       Date:  1979-07       Impact factor: 3.765

6.  Benzodiazepines: a summary of pharmacokinetic properties.

Authors:  D J Greenblatt; R I Shader; M Divoll; J S Harmatz
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

7.  The pharmacological profile of a potential hypnotic compound RU 31158.

Authors:  T G Johns; D C Piper; G W James
Journal:  Arch Int Pharmacodyn Ther       Date:  1979-07
  7 in total
  5 in total

1.  Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam, a new benzodiazepine hypnotic.

Authors:  G T McInnes; E A Bunting; R M Ings; J Robinson; S I Ankier
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

Review 2.  Pharmacokinetics of the newer benzodiazepines.

Authors:  P D Garzone; P D Kroboth
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

Review 3.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

4.  Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol.

Authors:  K Adam; I Oswald; C Shapiro
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 5.  Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia.

Authors:  B G Clark; S G Jue; G W Dawson; A Ward
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.